TP53 and neoplasm: Enzymes that regulate the methylation of lysine-rich N-terminal histone “tails” contribute to the epigenetic modulation of tumor-associated pathways, such as NF-κB and p53 signaling pathways (Agger et al., 2009; Park et al., 2016).